Azithromycin Dosing for Acute Upper Respiratory Tract Infection
For acute upper respiratory tract infections (URTIs), azithromycin is dosed at 500 mg once daily for 3 days in adults, or 10 mg/kg once daily for 3 days in children ≥6 months old. This represents the FDA-approved and guideline-supported regimen for bacterial URTIs including acute bacterial sinusitis and certain pharyngeal infections 1.
Adult Dosing
The standard adult dose is 500 mg orally once daily for 3 consecutive days 1. This 3-day regimen provides equivalent efficacy to longer courses of other antibiotics while improving compliance and reducing adverse effects 2, 3.
Alternative Adult Regimens:
- 5-day regimen: 500 mg on day 1, then 250 mg daily on days 2-5 (also FDA-approved for community-acquired pneumonia and pharyngitis) 1
- The 3-day course is preferred for acute bacterial sinusitis specifically 4
Important caveat: Azithromycin should NOT be used as first-line therapy for acute bacterial rhinosinusitis. Guidelines recommend amoxicillin-clavulanate as the preferred agent due to concerns about resistance patterns, particularly with Streptococcus pneumoniae 5. Azithromycin is reserved for patients with β-lactam allergies 4.
Pediatric Dosing (≥6 months old)
For children with acute bacterial sinusitis or otitis media, the recommended dose is 10 mg/kg once daily for 3 days (maximum 500 mg/day) 1, 6.
Specific Pediatric Regimens by Indication:
Acute Bacterial Sinusitis:
- 10 mg/kg once daily for 3 days 1
Acute Otitis Media (three options):
- Single-dose: 30 mg/kg as a single dose 1
- 3-day: 10 mg/kg once daily for 3 days 1
- 5-day: 10 mg/kg on day 1, then 5 mg/kg daily on days 2-5 1
Pharyngitis/Tonsillitis:
- 12 mg/kg once daily for 5 days (ages ≥2 years) 1
- For group A streptococcal pharyngitis, higher total doses (60 mg/kg per course) show superior bacterial eradication compared to 30 mg/kg courses 7
Practical Pediatric Dosing Table (3-day regimen):
| Weight | Dose per day | Total course |
|---|---|---|
| 5 kg (11 lbs) | 2.5 mL (100 mg/5 mL suspension) | 150 mg |
| 10 kg (22 lbs) | 5 mL | 300 mg |
| 20 kg (44 lbs) | 5 mL (200 mg/5 mL suspension) | 600 mg |
| 30 kg (66 lbs) | 7.5 mL | 900 mg |
| ≥40 kg (88 lbs) | 10 mL | 1200 mg |
Critical Clinical Considerations
When Azithromycin is NOT Appropriate:
- Common cold/viral URI: Antibiotics are never indicated 5, 8
- Influenza: Use antivirals, not antibiotics 8
- First-line acute bacterial rhinosinusitis: Use amoxicillin-clavulanate instead 5
- Uncomplicated pharyngitis without confirmed streptococcal infection: Avoid empiric antibiotics 9
When to Consider Azithromycin:
- β-lactam allergy in patients requiring antibiotics for confirmed bacterial URTI 4
- Atypical pneumonia pathogens (Mycoplasma, Chlamydophila) 6
- Confirmed group A streptococcal pharyngitis in penicillin-allergic patients 6
Resistance Concerns:
The predicted bacteriologic efficacy of azithromycin for acute bacterial rhinosinusitis is only 77-81% in adults and 78-80% in children, significantly lower than high-dose amoxicillin-clavulanate (90-92%) 4. This reflects increasing macrolide resistance in S. pneumoniae and limited coverage of β-lactamase-producing H. influenzae and M. catarrhalis.
Administration:
- Can be taken with or without food 1
- No dosage adjustment needed for renal impairment (GFR >10 mL/min), but use caution in severe renal impairment 1
- Avoid concurrent aluminum/magnesium-containing antacids (reduces absorption) 10
Adverse Effects:
Most common are gastrointestinal (diarrhea 4-7%, nausea 3-5%, abdominal pain 2-5%) 1. In pediatric studies, discontinuation rates due to adverse effects were approximately 1% 1. The 3-day regimen shows better tolerability than longer courses of comparator antibiotics 3, 11.
Monitoring:
Patients should show clinical improvement within 48-72 hours. Failure to improve warrants reevaluation and consideration of alternative diagnoses or resistant pathogens 6, 4.